Thursday, December 4, 2008

Orchid gets US FDA nod for divalproex sodium tabs

Orchid Chemicals & Pharmaceuticals Ltd has received approval from the US FDA for its Abbreviated New Drug Application for divalproex sodium delayed-release tablets USP, 125 mg, 250 mg & 500 mg.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)